Skip to content

US · LFVN · PACKAGED FOODS

LifeVantage Corporation (LFVN) intrinsic value and stock valuation

$4.15as of 2026-11-21 · Mkt cap 85.28M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

LifeVantage Corporation DCF and intrinsic value

InvestorsCraft values LFVN with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from LFVN’s statements →

LifeVantage Corporation Graham Number

Graham Number: $7.13d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Packaged Foods Lehi, UT 84043 lifevantage.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$228.5M-0.4% 5y CAGRd
20112025
Net income
$9.8M-3.2% 5y CAGRd
20112025
Free cash flow
$10.5M-7.6% 5y CAGRd
20112025
Total equity
$34.6M+0.8% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$228.5M$200.2M$213.4M$206.4M$220.2M
Operating income$12.2M$4.33M$4.26M$7.58M$17.6M
Net income$9.8M$2.94M$2.54M$3.12M$12.9M
EPSd$754.4K$226.3K$202.1K$238.7K$903.3K
Operating cash flow$11.9M$12.2M$6.83M$7.96M$7.96M
Capital expenditure-$-1.37M-$-2.25M-$-3.07M-$-1.53M-$-1.53M
Free cash flow$10.5M$9.95M$3.76M$6.43M$6.43M
Total assets$72M$60.3M$66.1M$70.7M$78.7M
Total debt$11.7M$13.6M$13.1M$15.8M$18.2M
Net debt-$-8.52M-$-3.27M-$-8.52M-$-4.43M-$-4.99M
Total equity$34.6M$26M$34.7M$31.5M$36.8M
Cash and short-term investments$20.2M$16.9M$21.6M$20.2M$23.2M
Income statement
20252024202320222021
Revenue$228.5M$200.2M$213.4M$206.4M$220.2M
Cost of revenue$44.9M$41.4M$43.4M$38.1M$38.2M
Gross profit$183.7M$158.7M$170M$168.3M$182M
Research and development expenses$0.00$0.00$0.00$0.00$700K
Selling, general and administrative expenses$69.2M$68.5M$71.1M$63.4M$164.4M
Other expenses$102.3M$85.9M$94.7M$97.3M-$-700K
Operating expenses$171.5M$154.4M$165.8M$160.7M$164.4M
Cost and expenses$216.3M$195.8M$209.1M$198.8M$202.6M
Interest income$430K$430K$200K$0.00$0.00
Interest expense$0.00$0.00$0.00$10K$20K
Depreciation and amortization$3.16M$3.58M$3.58M$3.26M$3.46M
Ebitda$15.4M$7.93M$7.58M$7.96M$20.7M
Operating income$12.2M$4.33M$4.26M$7.58M$17.6M
Total other income/expenses, net$40K$20K-$-260K-$-2.88M-$-380K
Income before tax$12.2M$4.35M$4M$4.69M$17.2M
Income tax expense$2.44M$1.41M$1.46M$1.57M$4.34M
Net income$9.8M$2.94M$2.54M$3.12M$12.9M
Weighted average shares outstanding$12.3M$12.5M$12.6M$12.9M$14.1M
Weighted average diluted shares outstanding$13M$13M$12.6M$13.1M$14.3M
Balance sheet
20252024202320222021
Cash and short-term investments$20.2M$16.9M$21.6M$20.2M$23.2M
Net receivables$3.93M$3.26M$1.85M$5.09M$3.96M
Inventory$20.7M$15.1M$16.1M$16.5M$16.1M
Total current assets$50.9M$37.7M$44.3M$47M$48.1M
Property, plant and equipment, net$14.3M$17.4M$17.8M$20.5M$24.8M
Goodwill and intangible assets$240K$320K$460K$590K$720K
Long-term investments$0.00$0.00$0.00$0.00$2.21M
Total non-current assets$21.1M$22.7M$21.8M$23.8M$30.7M
Total assets$72M$60.3M$66.1M$70.7M$78.7M
Accounts payable$5.06M$6.29M$4.22M$7.92M$7.59M
Short-term debt$1.87M$1.81M$1.52M$2.6M$2.15M
Deferred revenue$710K$860K$830K$80K$320K
Total current liabilities$27.2M$22.3M$19.6M$25.7M$25.2M
Long-term debt$9.81M$11.8M$11.6M$13.2M$16M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$10.1M$12M$11.9M$13.5M$16.7M
Capital lease obligations$11.7M$13.6M$13.1M$15.8M$18.2M
Total liabilities$37.3M$34.3M$31.5M$39.2M$41.9M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-104.15M-$-108.74M-$-98.31M-$-98.44M-$-92.35M
Accumulated other comprehensive income (loss)-$-1.18M-$-1.92M-$-1.36M-$-1.12M$100K
Total equity$34.6M$26M$34.7M$31.5M$36.8M
Total investments$0.00$0.00$0.00$0.00$2.21M
Total debt$11.7M$13.6M$13.1M$15.8M$18.2M
Net debt-$-8.52M-$-3.27M-$-8.52M-$-4.43M-$-4.99M
Cash flow statement
20252024202320222021
Net income$9.8M$2.94M$2.54M$3.12M$3.12M
Depreciation and amortization$3.16M$3.58M$3.58M$3.26M$3.26M
Stock-based compensation$5.7M$3.28M$3.19M$1.77M$1.77M
Change in working capital-$-6.55M$2.38M-$-2.56M-$-4.1M-$-4.1M
Accounts receivable-$-560K-$-1.5M$3.07M-$-1.33M-$-1.33M
Inventory-$-5.22M$660K$60K-$-1.19M-$-1.19M
Accounts payable-$-1.29M$2.3M-$-3.98M$820K$820K
Net cash provided by operating activities$11.9M$12.2M$6.83M$7.96M$7.96M
Investments in property, plant and equipment-$-1.37M-$-2.25M-$-3.07M-$-1.53M-$-1.53M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-1.37M-$-2.25M-$-3.06M-$-1.53M-$-1.53M
Common stock issued$280K$270K$250K$510K$0.00
Common stock repurchased-$-3.15M-$-7.65M-$-820K-$-9.08M-$-9.08M
Dividends paid-$-2.07M-$-6.94M-$-1.59M-$-380K-$-380K
Net cash used for financing activities-$-7.6M-$-14.42M-$-2.36M-$-8.95M-$-8.95M
Net change in cash$3.31M-$-4.72M$1.42M-$-2.98M-$-2.98M
Cash at end of period$20.2M$16.9M$21.6M$20.2M$20.2M
Operating cash flow$11.9M$12.2M$6.83M$7.96M$7.96M
Capital expenditure-$-1.37M-$-2.25M-$-3.07M-$-1.53M-$-1.53M
Free cash flow$10.5M$9.95M$3.76M$6.43M$6.43M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About LifeVantage Corporation

        LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.

        CEO
        Michael A. Beindorff
        Employees
        238
        Beta
        0.76

        Explore

        Frequently asked questions

        What is the intrinsic value of LifeVantage Corporation (LFVN)?

        LifeVantage Corporation (LFVN) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is LFVN undervalued?

        LFVN trades at a price of $4.15 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.